conolidin to Replace traditional Painkillers Options

Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors during the central anxious program, conolidine modulates alternate molecular targets. A Science Advances research uncovered that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXCR

read more